Glaxo (GSK) Sues Hospira (HSP) Over Quality of Flu Vaccine Supply - Bloomberg
Tweet
Share
E-mailGet Alerts GSK Hot Sheet
Up)Join SI Premium – FREE
GlaxoSmithKline PLC ADS (NYSE: GSK) said to sue Hospira (NYSE: HSP) over quality of influenza vaccine supply, according to Bloomberg headlines.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GSK (GSK) call put ratio 12 calls to 1 put with focus on April weekly (26) 41 calls
- Meta releases early versions of its Llama 3 AI model
- Comerica stock outperforms peers after profit beat
Create E-mail Alert Related Categories
General News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
